Obesity is associated with an increased risk of at least thirteen cancers and with negative cancer outcomes including increased metastasis, impaired response to therapy, elevated risk of recurrence, and an increase in cancer-related mortality 2,3,4,5
Treatment for Stevens-Johnson syndrome includes: corticosteroids to control inflammation antibiotics to prevent or control skin infections intravenous (IV) immunoglobulins to halt the progress of the disease There are no diagnostic tests for sulfa allergy
The consequences of injecting bacteria directly into subcutaneous tissue include: Injection site infections (redness, swelling, warmth, pain) Abscess formation requiring medical drainage Cellulitis (spreading skin infection) In rare cases, bloodstream infections requiring hospitalization This risk is higher with compounded semaglutide vials than with brand-name pens, because vials require repeated needle punctures through a rubber septum, creating more opportunities for contamination
Several telehealth brands carry the new GLP-1 pill
